Kestra Medical Technologies, Ltd.
KMTS
$27.90
-$0.45-1.59%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.39% | -58.85% | -60.96% | -29.88% | -133.59% |
| Total Depreciation and Amortization | 26.63% | 5.03% | 26.97% | -14.61% | -47.57% |
| Total Amortization of Deferred Charges | 26.83% | 175.88% | -29.20% | 134.50% | 84.50% |
| Total Other Non-Cash Items | -55.07% | 519.18% | 354.51% | 142.69% | 1,830.02% |
| Change in Net Operating Assets | 375.78% | 687.78% | 127.20% | -315.06% | -181.09% |
| Cash from Operations | 22.18% | -2.05% | -1.59% | -50.15% | -60.93% |
| Capital Expenditure | -30.31% | -122.26% | -62.20% | -17.17% | -76.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,254,261.54% | -11,572.09% | -60.78% | 60.87% | -69.05% |
| Cash from Investing | -2,232.60% | -235.26% | -67.87% | -17.03% | -78.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.73% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.51% | 8.40% | 95.30% | -114.59% | -1,210.61% |
| Cash from Financing | -100.09% | 125,463.03% | 95.30% | -101.61% | 1,654.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.57% | 613.59% | -11.88% | -139.67% | 2,766.90% |